Sickle Cell Patient’s Success with Gene Editing Raises Hopes and Questions

March 17, 2023

(NPR) – Almost four years ago, Gray became one of the first patients with a genetic disorder — and the first patient with sickle cell disease — to get an experimental treatment that uses the revolutionary gene-editing technique known as CRISPR. Today, all of Gray’s symptoms are gone, and she was in London last week to describe her landmark experience at the Third International Summit on Human Genome Editing. The summit brought together more than 400 scientists, doctors, patients, bioethicists and others from around the world to air the promise of gene editing as well as a host of thorny questions that the technology is raising. (Read More)